THIS WEEK!!!!! Come learn about viruses 🦠😍 @antiviral-rskating.bsky.social @livuni-ismib.bsky.social @livuni-ives.bsky.social @britsciassoc.bsky.social

Excellent 1st LINC #Neuroscience Seminar from Prof Jenkinson, Mr Nish Srikandaraja & Mr Ali Baksh on #Neurosurgery #research focusing on #meningioma & #spinal Follow us for our monthly series: @lincneurosci.bsky.social @liverpooluni.bsky.social @livuni-ismib.bsky.social @livuni-ives.bsky.social

Welcome to September! Tomorrow Tues 2nd September '25, 1-2pm Dr Yuewei Xu (Academy of Pharmacy⭐️, XJTLU, China). Presents "RNA splicing – gateway to cancer vulnerabilities" Pharmacology Seminar Room – Sherrington Building (1st floor). Host: Professor Chris Goldring @livuni-ismib.bsky.social

BLOG | School of Biosciences graduate Jemma Clarke tells us about her summer of science last year on a research placement with Professor Daniel Rigden ➡️ bit.ly/4mMbftK #TeamLivUni

Incredible experience with working with the team @exeter.ac.uk to understand how to integrate cutting edge citizen science into our brand new year 2 undergrad Biosciences practicals @livuni-ismib.bsky.social @livunihls.bsky.social

A call for participants! Colleagues at University of Liverpool seek participants with a diagnosis of #cancer and #dementia, #Parkinson's, #stroke, their relatives, health staff to explore experiences of #cancercare in #NorthWest #England supported by North West Cancer Research. More info on flyers ⤵️

We’re proud to invite you to ISMIB Pride 2025, a university-wide celebration of diversity, inclusion, and community — and you’re all welcome to join us! 31st July! @livuni-ismib.bsky.social

Liverpool welcomed over a thousand international delegates this month as it hosted the 10th World Congress of the International Academy of Oral Oncology (IAOO)—bringing together leaders in the fight against oral cancer. @livunihls.bsky.social news.liverpool.ac.uk/2025/07/30/l...

Today our @livuni-ismib.bsky.social School of Biosciences team celebrated the achievements of another incredible cohort of undergraduates. It’s an honour to be a small part of their story.

🌟 You’ve made it! 🌟 Congratulations to our Biosciences students graduating this afternoon, your hard work and dedication have got you here and we’re so proud! 🎓 You can find the livestream of the ceremony on our website: bit.ly/3IjIIge #TeamLivUni

NEWS I @livuni-ismib.bsky.social researchers have begun work on a major £2.7 million @nihr.bsky.social-funded trial investigating the long-term effectiveness of vagus nerve stimulation in people with drug-resistant epilepsy. Read more ⬇️ news.liverpool.ac.uk/2025/07/16/2... @livunihls.bsky.social

Congratulations to Professor Sir Munir Pirmohamed, who has been recognised with a Lifetime Achievement Award by the European Association for Clinical Pharmacology and Therapeutics (EACPT). ➡️ bit.ly/44xsGbk @eacpt.bsky.social | #TeamLivUni

📢 3 PhD positions available in the Raval group! ⏰ Deadline 1st of September 2025 🧑‍🔬 The selected students will be enrolled in the @ukbiofilms.bsky.social BITE doctoral training programme. Follow the link to apply 👇 www.liverpool.ac.uk/antimicrobia... @livunisps.bsky.social #MicroSky

Have you caught up on Episode 9 of the Original Ideas podcast? 🎙️   With insights from Professor Neil Liptrott, Dr Rishi Mukherjee, and Dr Danielle Brain, this episode offers a compelling look at the future of global healthcare.   🎧 Catch up now: www.liverpool.ac.uk/research/ori...

In an article in The Conversation (@uk.theconversation.com) CELT's Co-Director, Professor Andrew Owen explains everything we need to know about lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. ➡️ bit.ly/3ZZOMQW @livuninews.bsky.social | #TeamLivUni

It's LIVE! #BSF25 I can now announce that I have created "Antiviral Skating" 🛼🦠✨️ A collaboration with @livuni-ismib.bsky.social & Liverpool Roller Birds Friday 12th September. 18.30 at @ Unity Theatre FREE tickets 👇🏾 britishscienceassociation-tickets.ticketsolve.com/ticketbooth/...

JOIN US! We're looking for an exceptional academic to develop the pharmaceutics content of our new Master of Pharmacy Undergraduate programme. 📅 Applications close: Thursday 14 August Find out more and apply here ➡️ bit.ly/3G9TXap #TeamLivUni

Join Pharmacology and Therapeutics for 'Liverpool's Party People' exploring the science of a night out. britishsciencefestival.org/event/liverp...

In our latest episode of the Original Ideas podcast, Professor Neil Liptrott, Dr Rishi Mukherjee, and Dr Danielle Brain discuss the our pioneering research and its translation into practical medical solutions through the Therapeutics Innovation Research Frontier. Listen now ➡️ brnw.ch/21wTNVh

We were delighted to join the Careers Carousel at St Anne's Catholic Primary school this week and share insights of our work with the Year 6 children. #STEM #engagement #clinicalscience @livuniengagehls.bsky.social @livuni-ismib.bsky.social

🎙️Original Ideas Podcast Ep9 Therapeutics Innovation @liverpooluni.bsky.social's Neil Liptrott, Dr Rajarshi (Rishi) Mukherjee, and Dr Danielle Brain discuss groundbreaking discoveries in research of infectious diseases and global health. Listen ▶️ www.liverpool.ac.uk/research/ori...

💉 In the US, the Food and Drug Administration (FDA) have approved twice-yearly #longacting injections of lenacapavir for #HIV prevention. In this article @celtliverpool.bsky.social's Prof. Andrew Owen explains what this means for people living with HIV. 👉 theconversation.com/us-approves-...

In a project funded by the BBSRC and led by @northumbriauni.bsky.social, Professor Neill Liptrott (@profliptrott.bsky.social) is investigating how viruses can potentially be used to promote gut health in premature babies 🍼 ➡️ bit.ly/4e59sNe #TeamLivUni

New UK report sees patients and professionals call for more inclusive, accessible medicines research and care ⬇️ 💊🏥 news.liverpool.ac.uk/2025/06/23/n... @livuni-ismib.bsky.social @livunihls.bsky.social @nihr.bsky.social @reechasofat.bsky.social

Congratulations to Dr Aphrodite Vasilaki and Dr Paraskevi Kritsiligkou @parikki.bsky.social who won the Leopold Flohé Redox Pioneer Young Investigator Award and Catherine Pasquier Award respectively at the 2025 Society for Free Radical Research International meeting ▶️ bit.ly/4ebZ9XN

NEWS | The University of Liverpool is leading GreenNanoBone, an €8.6M EU project using AI and plant waste to tackle MRONJ—a severe jaw condition affecting cancer survivors. Read more ⬇️ news.liverpool.ac.uk/2025/06/17/l...

This week you can join our seminar online @livuni-ismib.bsky.social please check emails for Zoom link Friday 20th June 2025, 11am – 12pm. Guest Speaker – Max Mazzone Title – “Harnessing tumor metabolism to overcome immunosuppression” Host – @mcschmid.bsky.social Location – Zoom

🧠 Heading to #EACPT2025 next weekend? DynAIRx Co-PI Professor Lauren Walker will be chairing a session on AI in drug development — exploring how machine learning is shaping the future of medicines discovery and use - come say hello! #AIinHealth @livunichil.bsky.social @therexuol.bsky.social

Today myself, Nordine, Jill and Melissa represented @livuni-ismib.bsky.social PE team today at the Staff awards. It was lovely to make it onto the shortlist and receive a commendation. Congratulations to the C-GULL team for winning the Outstanding Contribution to PE award.

Great talk from Bin-Zhi Qian on macrophages and bone metastasis today at our Liverpool Cancer Seminar Series @livuni-ismib.bsky.social @livunicancer.bsky.social

Rajarshi (Rishi) Mukherjee, a Medical Research Council (MRC)/GlaxoSmithKline (GSK) @surgeonscientist.bsky.social based at @liverpooluni.bsky.social’s Institute of Systems, Molecular and Integrative Biology, delivered the Hunterian Lecture ‪‪@rcsed.bsky.social‬ ▶️ www.liverpool.ac.uk/research/new...

The Enterprise Team has arranged for a representative from CancerTools to visit the University on 9 June. This unique organisation is a global, non-profit, cancer-focused, research tools biorepository. ➡️For more details – bit.ly/4jqfIQQ To register for a 1-1, contact [email protected]

BECOMING AN EXPERT | Here Mr George Nita, PhD candidate in Bioinformatics tells us about his work to revolutionise kidney transplant care. His goal? A simple blood test that detects rejection before it causes harm⬇️ news.liverpool.ac.uk/2025/05/29/b... @livunihls.bsky.social

Postcard: Dr Josh Gardner, a postdoctoral researcher from Pharmacology and Therapeutics, recently received the inaugural BTS-ASPET Lecture Award. Here he tells us about his trip to the USA to share breakthroughs in drug allergy and toxicology. ➡️ bit.ly/45kpqR8 #ECR | #TeamLivUni

Join Dr Adam Burke in our latest blog as he discusses his work as a NERC Environmental Omics Facility Research Associate. ➡️ bit.ly/3FmPO2e @livuni-livsrf.bsky.social | #Metabolomics | #TeamLivUni

We are thrilled @brainiigroup.bsky.social to congratulate a double PhD success with Corey Ratcliffe and Cory Hooper. Both have done tremendously well and passed their VIVAs.👨‍🎓🧠🎉 @livuni-ismib.bsky.social @livuni-ives.bsky.social

Great night last night, taking pharmacology to the pub @pintofscience.uk - some great talks and fantastic shots of science! My talk focused on how we got treatments to patients during the COVID pandemic @therexuol.bsky.social @livuni-ismib.bsky.social @livuniengagehls.bsky.social

🎉Congratulations to Professor Richard Scheltema (@scheltemalab.bsky.social), who has been awarded a prestigious Academy of Medical Sciences Professorship! ➡️ bit.ly/4dkvbjN @livuni-livsrf.bsky.social | @livuninews.bsky.social | #TeamLivUni

🎉 Congratulations to Dr Gemma Wattret from our School of Biosciences, who has been shortlisted for @rsb.org.uk's Higher Education Biosciences Teacher of the Year award. ➡️ bit.ly/4darSeR #Biosciences | #TeamLivUni

Fabulous first volume EM image stack from our new @zeiss-microscopy.bsky.social Volutome system and @aliemliv.bsky.social and her talented team. External users and projects welcome! @livuni-livsrf.bsky.social @livuni-ismib.bsky.social www.linkedin.com/posts/alison...

Very proud of this study from my PhD student Medina @medina0396.bsky.social 👏🏻🎉 showing how the immune checkpoint receptor VISTA regulates macrophages in triple negative breast cancer to suppress T cells. @mcschmid.bsky.social @livunicancer.bsky.social @livuni-ismib.bsky.social rdcu.be/ekqtp

Have you considered taking part in a clinical trial? We are recruiting to 2 clinical studies. Get in contact if you are interested. #clinicaltrial #research #BePartofResearch #volunteer @livuni-ismib.bsky.social @livunihls.bsky.social @nhsuhlg-ri.bsky.social

A clinical trial is underway in Liverpool to tackle one of the world’s deadliest parasitic diseases, visceral leishmaniasis. The study is testing a new oral treatment that could replace painful daily injections & save thousands of lives in low-income regions ⬇️ news.liverpool.ac.uk/2025/04/24/l...

A privilege to work with such a talented interdisciplinary team on this. @livuni-livsrf.bsky.social @livuni-ismib.bsky.social @aliemliv.bsky.social www.science.org/doi/10.1126/...

📅A date for your diaries. Our Research assistant and PhD candidate @lizchallenger.bsky.social will be speaking at the Pint of Science festival @livuniengagehls.bsky.social @livuni-ismib.bsky.social

NEWS | A delegation from the Kenyan Medical Research Institute (KEMRI) recently visited @liverpooluni.bsky.social. The two institutes came together to discuss advancements in research and further cemented their commitments to improving health outcomes. ➡️ bit.ly/42GXjde #TeamLivUni

NEWS I First-ever analysis of UK's clinical trial landscape by @mhragovuk.bsky.social & @liverpooluni.bsky.social reveals UK is a global leader in clinical research & sets out key opportunities to deliver even more life-changing treatments for patients 🔬 🧪 ⬇️ news.liverpool.ac.uk/2025/04/10/m...

Professor Ben Goult (@bengoult.bsky.social) recently delivered his inaugural lecture, giving a deeply personal account of his career to date, as well as convincing the audience of the wondrous mechanical properties of the protein talin. ➡️ bit.ly/3RLrBFi #TeamLivUni

MCCM's Judy Coulson and team have recently published work identifying that targeting a protein, OTUD6B, may prevent aggressive triple-negative breast cancer cells from growing and dividing. The discovery could lead to more effective, targeted treatments for this challenging form of breast cancer.

Congratulations to Dr Pei Yee Tey (@impeiyee.bsky.social) from our Department of Biochemistry, Cell and Systems Biology, winner of the British Society of Cell Biology's 2025 Raff Medal for her research. ➡️ bit.ly/42evg4V #PhD | #BSCB | #TeamLivUni